Phase II Study of Combined Chemotherapy With Arsenic Trioxide in Stage 4/M Neuroblastoma
NCT03503864
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Neuroblastoma
Interventions
DRUG:
Arsenic Trioxide
Sponsor
Yang Li